The European Union approved a new version of Wyeth's hemophilia B drug BeneFix. The improved product contains a lower diluent volume for all dosage strengths, comes in a prefilled syringe, has a bigger IU vial and features a needle-less reconstitution device. Wyeth hopes these changes will make the treatment easier for patients to prepare and use.

Related Summaries